TR5 TR10 TR15 TR20 TR60 Tirzepatide raw powder cas 2023788-19-2
TDS 2100 Inquiries
2023788-19-2
Pharmaceutical Grade
99%
HONGKONG
XICAI
10vials/box
Yes
2027-11-25
Semaglutide,Tirzepatide,Retatrutide,DSIP,Selank,Oxytocin Acetate
-
Product Details
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial Reference
Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.
Certificates-
TDS
Basic Info-
Product Name:
Tirzepatide
Other Name:LY3298176;
CAS No.:2023788-19-2
Molecular Formula:C225H348N48O68
Molecular Weight:4813
EC Number:200-001-8
Categories:
Characteristics-
Appearance:
White to off-white
Research-
Class:
Dual agonist — GIPR, GLP-1R
Status:FDA-approved (Mounjaro / Zepbound)
Mechanism:Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.
EC50 (Human GLP1R):0.934 nM
EC50 (Human GIPR):0.0224 nM
Source:Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI
Clinical Development:NCT03954834; NCT03987919; NCT03882970; NCT03730662; NCT04039503
FDA:Mounjaro, Zepbound (approved 2022-05-13)
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Disclaimer:
Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Semaglutide,Tirzepatide,Retatrutide,DSIP,Selank,Oxytocin Acetate
-
Location:
Yiwu Xichai Biotechnology Co., Ltd.
-
Payment Terms:
TT against copy of documents,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
2 days
-
Total Annual Revenue:
$10 million-$25 million
-
Total Employees:
5-10
-
Year of Establishment:
2026
-
-
Inquiry History2100 Inquiries
Country Product Purchase Quantity Date Posted
Slovakia
Tirzepatide
1 G Oct 26, 2026
France
Tirzepatide
1 KG Oct 25, 2026
United States
Tirzepatide
2.5 MG Oct 25, 2026
United Kingdom
Tirzepatide
5 MT Oct 25, 2026
United Kingdom
Tirzepatide
6 MT Oct 24, 2026
Peru
tirzepatide
10 MG Oct 21, 2026
Puerto Rico
tirzepatide
40 MG Oct 21, 2026
United States
Tirzepatide
10 MT Oct 21, 2026
South Africa
Tirzepatide
1 MT Oct 20, 2026
United States
Tirzepatide
5 KG Oct 20, 2026
United States
tirzepatide
30 MG Oct 20, 2026
United States
Tirzepatide
50 MG Oct 20, 2026
Spain
tirzepatide
20 MG Oct 19, 2026
United States
tirzepatide
30 MG Oct 19, 2026
Philippines
tirzepatide
40 MG Oct 19, 2026
United States
tirzepatide
50 MG Oct 19, 2026
United States
tirzepatide
50 MG Oct 19, 2026
United States
Tirzepatide
20 MG Oct 19, 2026
United States
Tirzepatide
300 MG Oct 19, 2026
China
Tirzepatide
21 MT Oct 17, 2026 Post an enquiry for this product
More from this Seller
-
-
-
factory peptide peptide powder peptide vial custom peptides Chemical Retatrutide rt10
Pharmaceutical Grade / 99%
$1/UNIT FOB
-
-
-
-
China Factory Wholesale KLOW80 | GLOW | Retatrutide | GHK-CU | 99% Purity | Wholesale Custom Peptides
Pharmaceutical Grade / 99%
$50/MT FOB
-
-
-
-
Humanin | US Warehouse | Cosmetic Peptides | 99% Purity | 10mg 50mg Vials | Lyophilized
Pharmaceutical Grade / 99%
$5/UNIT FOB
-
-
-
-
High Purity DSIP 62568-57-4 Delta Sleep-Inducing Peptide Lyophilized Powder 99% Neuroregulation Research Peptide
Pharmaceutical Grade / 99%
$50/MT FOB
-
